Chlorpromazine in chronic schizophrenia: behavioral dose-response relationships.
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced; D000704:Analysis of Variance; D000740:Anemia / Q000139:chemically induced; D001519:Behavior / Q000187:drug effects; D002746:Chlorpromazine / Q000008:administration & dosage* / Q000009:adverse effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003248:Constipation / Q000139:chemically induced; D003863:Depression / Q000139:chemically induced; D003875:Drug Eruptions; D004890:Erythema / Q000139:chemically induced; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005260:Female; D006801:Humans; D008796:Metrorrhagia / Q000139:chemically induced; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*
D010919:Placebos; D002746:Chlorpromazine